Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.0K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.0K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

3.0K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
3.0K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

545
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
545
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

259
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
259
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

481
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
481
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

357
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
357

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

The Journal of antimicrobial chemotherapy·2026
Same author

Global mobility flows and COVID-19 spread in Europe during the emergency phase: Insights from Meta-Facebook data.

Spatial and spatio-temporal epidemiology·2026
Same author

Heterologous vaccination with a next-generation vaccinia virus and Ad26 induces Ebola-specific immunity in macaques.

NPJ vaccines·2026
Same author

CD155 links tumor immunotype to epithelial-directed precision therapy beyond checkpoint inhibition in cervical cancer.

Journal for immunotherapy of cancer·2026
Same author

Early transcriptional responses following Ad26.COV2.S vaccination in individuals with prior SARS-CoV-2 infection.

EBioMedicine·2026
Same author

Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast-Track Regulatory Frameworks.

Statistics in medicine·2026

Related Experiment Video

Updated: Jan 27, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.4K

Bayesian sequential integration within a preclinical pharmacokinetic and pharmacodynamic modeling framework: Lessons

Fabiola La Gamba1,2, Tom Jacobs1, Helena Geys1,2

  • 1Department of Quantitative Sciences, Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium.

Pharmaceutical Statistics
|April 2, 2019
PubMed
Summary

This study explores integrating knowledge from small preclinical trials using Bayesian pharmacokinetic/pharmacodynamic (PK/PD) modeling. It highlights challenges and offers guidance for effective sequential knowledge integration in drug development.

Keywords:
Bayesian inferencenonlinear hierarchical modelspharmacodynamicspharmacokineticsrecursivesequential

More Related Videos

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
08:41

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

23.9K
Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

3.0K

Related Experiment Videos

Last Updated: Jan 27, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.4K
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
08:41

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

23.9K
Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

3.0K

Area of Science:

  • Pharmacometrics
  • Pharmacokinetics and Pharmacodynamics (PK/PD)
  • Bayesian Statistics

Background:

  • Sequential knowledge integration from small preclinical trials is crucial for efficient drug development.
  • Bayesian pharmacokinetic and pharmacodynamic (PK/PD) frameworks offer a natural approach for integrating new data over time.

Purpose of the Study:

  • To discuss the implications of sequential knowledge integration in small preclinical trials within a Bayesian PK/PD framework.
  • To highlight often-overlooked challenges and provide guidance on choices in sequential data integration.
  • To explore the impact of prior specification, random effects, and integration methods on sequential strategies.

Main Methods:

  • Discussion of Bayesian pharmacokinetic and pharmacodynamic (PK/PD) modeling.
  • Analysis of sequential knowledge integration strategies.
  • Consideration of prior specification, random effects, and integration methods.
  • Emphasis on experimental design for small trial analysis.

Main Results:

  • Bayesian PK/PD frameworks present challenges for sequential knowledge integration.
  • Key factors influencing success include prior specification, random effects choice, and integration method.
  • Effective sequential integration is highly dependent on a well-designed experimental approach for small trials.

Conclusions:

  • Sequential knowledge integration in Bayesian PK/PD models requires careful consideration of methodological choices.
  • Addressing challenges related to priors, random effects, and integration methods is essential.
  • Optimizing experimental design is critical for successful sequential analysis of small preclinical trials.